Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV Read more about Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US Application 17/115,026Filed on 2020-12-08
SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES Read more about SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES US Patent 11,939,356Filed on 2021-03-15
Improvement Of HIV-neutralizing Antibodies By Modification Of The Heavy Chain FR3 Loop And Other Regions Read more about Improvement Of HIV-neutralizing Antibodies By Modification Of The Heavy Chain FR3 Loop And Other Regions Patent Cooperation TreatyPCT/US2020/062493Filed on 2020-11-27
Improved Methods Of Manufacturing Peptide-Based Vaccines Read more about Improved Methods Of Manufacturing Peptide-Based Vaccines US Application 17/057,658Filed on 2020-11-21
PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA Read more about PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA US Application 17/115,317Filed on 2020-12-08
Development Of Dengue Virus Vaccine Components Read more about Development Of Dengue Virus Vaccine Components BrazilBR122020023372-9Filed on 2020-11-16
Development Of Dengue Virus Vaccine Components Read more about Development Of Dengue Virus Vaccine Components BrazilBR122020023371-0Filed on 2020-11-16
Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 Read more about Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 BrazilBR1220200231563Filed on 2020-11-12
PREFUSION PIV F IMMUNOGENS AND THEIR USE Read more about PREFUSION PIV F IMMUNOGENS AND THEIR USE US Patent 11,845,778Filed on 2021-07-16
ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION Read more about ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION US Application 17/052,470Filed on 2020-11-02